Harvard Apparatus (HART) Regenerative Technology Reports Fourth Quarter And Year Ended December 31, 2013 Operating Results
3/10/2014 6:36:28 AM
Harvard Apparatus Regenerative Technology, Inc. (Nasdaq: HART), a clinical stage biotechnology company developing regenerated organs for transplant, initially focused on the trachea, today reported unaudited financial results for the three months and year ended December 31, 2013.
Help employers find you! Check out all the jobs and post your resume.
comments powered by